AA
AlphaCentric Advisors Portfolio holdings
AUM
$100M
This Quarter Return
+5.44%
1 Year Return
+18.84%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$180M
AUM Growth
+$180M
(+24%)
Cap. Flow
+$31.5M
Cap. Flow
% of AUM
17.49%
Top 10 Holdings %
Top 10 Hldgs %
21.59%
Holding
287
New
77
Increased
46
Reduced
73
Closed
55
Top Buys
| 1 |
Jazz Pharmaceuticals
JAZZ
|
$4.18M |
| 2 |
Invesco S&P 500 Pure Value ETF
RPV
|
$2.42M |
| 3 |
Coherus Oncology, Inc. Common Stock
CHRS
|
$2.38M |
| 4 |
iShares Russell 1000 Value ETF
IWD
|
$2.37M |
| 5 |
Amylyx Pharmaceuticals
AMLX
|
$2.17M |
Top Sells
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
$4.07M |
| 2 |
Invesco QQQ Trust
QQQ
|
$2.81M |
| 3 |
Invesco NASDAQ 100 ETF
QQQM
|
$2.81M |
| 4 |
Innoviva
INVA
|
$2.07M |
| 5 |
Bio-Rad Laboratories Class A
BIO
|
$1.63M |
Sector Composition
| 1 | Healthcare | 59.95% |
| 2 | Real Estate | 10.67% |
| 3 | Financials | 4.01% |
| 4 | Technology | 3.11% |
| 5 | Consumer Discretionary | 2.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
KalVista Pharmaceuticals
KALV
$719M
| $1.22M | 0.67% |
+135,000
| New | +$1.22M |
|
52
Allient
ALNT
$766M
| $1.2M | 0.66% |
30,000
-5,000
| -14% | -$200K |
|
53
Acadia Pharmaceuticals
ACAD
$4.33B
| $1.2M | 0.66% |
50,000
| – | – |
|
|
VRNA
54
Verona Pharma
VRNA
$9.18B
| $1.16M | 0.65% |
55,000
| – | – |
|
55
Verastem
VSTM
$567M
| $1.12M | 0.62% |
+150,000
| New | +$1.12M |
|
56
Omnicell
OMCL
$1.47B
| $1.11M | 0.61% |
15,000
| – | – |
|
57
Alkermes
ALKS
$4.85B
| $1.1M | 0.61% |
35,000
-10,000
| -22% | -$313K |
|
|
DCPH
58
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $1.09M | 0.61% |
77,500
+5,000
| +7% | +$70.4K |
|
59
Synopsys
SNPS
$110B
| $1.09M | 0.6% |
2,500
| – | – |
|
60
Symbotic
SYM
$5.07B
| $1.07M | 0.59% |
+25,000
| New | +$1.07M |
|
61
Enact Holdings
ACT
$5.53B
| $1.06M | 0.59% |
42,367
+17,000
| +67% | +$427K |
|
62
Collegium Pharmaceutical
COLL
$1.23B
| $1.06M | 0.59% |
49,500
| – | – |
|
63
AeroVironment
AVAV
$12B
| $1.02M | 0.57% |
10,000
-5,000
| -33% | -$511K |
|
64
Mobileye
MBLY
$11.2B
| $961K | 0.53% |
25,000
| – | – |
|
|
RWT
65
Redwood Trust
RWT
$773M
| $934K | 0.52% |
146,593
| – | – |
|
66
SoundHound AI
SOUN
$5.47B
| $910K | 0.5% |
+200,000
| New | +$910K |
|
67
Welltower
WELL
$112B
| $895K | 0.5% |
11,059
| – | – |
|
68
argenx
ARGX
$43.2B
| $877K | 0.49% |
+2,250
| New | +$877K |
|
69
Crinetics Pharmaceuticals
CRNX
$3.14B
| $847K | 0.47% |
+47,000
| New | +$847K |
|
|
ONIT
70
Onity Group Inc.
ONIT
$335M
| $845K | 0.47% |
28,195
-7,423
| -21% | -$222K |
|
71
Viridian Therapeutics
VRDN
$1.56B
| $845K | 0.47% |
35,500
| – | – |
|
72
Stereotaxis
STXS
$246M
| $842K | 0.47% |
550,000
| – | – |
|
73
iTeos Therapeutics
ITOS
| $834K | 0.46% |
63,000
| – | – |
|
74
iShares 3-7 Year Treasury Bond ETF
IEI
$16.7B
| $798K | 0.44% |
6,920
+2,225
| +47% | +$256K |
|
75
Annaly Capital Management
NLY
$13.5B
| $750K | 0.42% |
37,500
| – | – |
|